This review systematically examines the potential of spices and culinary herbs (e.g., turmeric, garlic, ginger) for breast cancer (BC) prevention and treatment, elucidating their underlying mechanisms: inhibiting BC cell proliferation, migration, and metastasis; inducing apoptosis and cell cycle arrest; and modulating dysregulated signaling pathways (e.g., PI3K/Akt/mTOR, NF-κB, Wnt/β-catenin). Notably, their bioactive constituents (e.g., curcumin from turmeric, allicin from garlic, gingerol from ginger) exhibit anti-BC efficacy with fewer adverse effects than conventional chemotherapeutics.

Importantly, it synthesizes in vitro, in vivo, and clinical evidence—for instance, phase I/II trials demonstrating that curcumin combined with docetaxel or paclitaxel improved outcomes in patients with advanced BC. Clinically, these natural agents represent safe, accessible adjuncts to standard BC therapies, though additional large-scale, well-designed clinical trials are required to validate their translational value.

Quitting smoking in middle age or later is linked to slower age-related cognitive decline over the long term, according to a new study by UCL (University College London) researchers.

A new UCLA Health study highlights concerning gaps in how child neurologists understand and address motor difficulties in children with autism, despite research showing these movement problems affect the majority of autistic children and can significantly impact their development.